Canagliflozin Prevents Diabetes-Induced Vascular Dysfunction in ApoE-Deficient Mice

Aim: Recent studies have demonstrated that selective sodium–glucose cotransporter 2 inhibitors (SGLT2is) reduce cardiovascular events, although their mechanism remains obscure. We examined the effect of canagliflozin, an SGLT2i, on atherogenesis and investigated its underlying mechanism. Method: Can...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:J Atheroscler Thromb
Päätekijät: Rahadian, Arief, Fukuda, Daiju, Salim, Hotimah Masdan, Yagi, Shusuke, Kusunose, Kenya, Yamada, Hirotsugu, Soeki, Takeshi, Sata, Masataka
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Japan Atherosclerosis Society 2020
Aiheet:
Original Article
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC7803832/
https://ncbi.nlm.nih.gov/pubmed/32101837
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5551/jat.52100
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia